PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Mega, Jessica L.
TI  - Escalating Clopidogrel by Involving a Genetic Strategy-TIMI 56
DP  - 2011  01
TA  - MD Conference Express
PG  - 11--11
VI  - 11
IP  - 15
4099  - http://mdc.sagepub.com/content/11/15/11.short
4100  - http://mdc.sagepub.com/content/11/15/11.full
AB  - Results of the EscaLating ClopidogrEl by InVolving A GeneTic StratEgy — Thrombolysis In Myocardial Infarction 56 [ELEVATE TIMI 56] trial showed that tripling the maintenance dose of clopidogrel in CYP2C19*2 heterozygote patients achieved levels of platelet reactivity that were similar to the standard-dose clopidogrel in noncarriers.